Application
BCL9L Antibody (N-term) western blot analysis in human placenta tissue lysates (35ug/lane).This demonstrates the BCL9L antibody detected the BCL9L protein (arrow).| Product Name | BCL9L(N-term) |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | BCL9L; DLNB11; B-cell CLL/lymphoma 9-like protein; Protein BCL9-2 |
| Clonality | Polyclonal |
|---|---|
| Isotype | Ig |
| Host Species | Rabbit |
| Tested Applications | WB |
| WB:1:100~500 |
|
| Species Reactivity | Human |
| Concentration | 1mg/ml |
| Gene Synonyms | DLNB11 |
|---|---|
| Alternative Names | BCL9L DLNB11 B-cell CLL/lymphoma 9-like protein Protein BCL9-2 |
| Molecular Weight(MW) | 157129 Da |
| Function | Transcriptional regulator that acts as an activator. Promotes beta-catenin transcriptional activity. Plays a role in tumorigenesis. Enhances the neoplastic transforming activity of CTNNB1 (By similarity) |
| Tissue Specificity | Expressed in breast, ductal and invasive ductal carcinomas of the breast, sporadic colorectal adenomas and carcinomas (at protein level). Expressed in fetal brain. Expressed in lung, amygdala, eye, prostate, pancreatic and prostate cancers, head and neck tumors and embryonal tumor |
| Cellular Localization | Nucleus. |
| Entrez Gene | 283149 |
|---|---|
| Nucleotide Accession | NP_872363.1 |
Application
BCL9L Antibody (N-term) western blot analysis in human placenta tissue lysates (35ug/lane).This demonstrates the BCL9L antibody detected the BCL9L protein (arrow).| Application Notes | WB:1:100~500 |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. |
